Contaminated Cocaine and Antineutrophil Cytoplasmic Antibody-Associated Disease
- 1 December 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 6 (12), 2799-2805
- https://doi.org/10.2215/cjn.03440411
Abstract
Background and objectives Approximately 70% of illicit cocaine consumed in the United States is contaminated with levamisole. Most commonly used as a veterinary antihelminthic agent, levamisole is a known immunomodulating agent. Prolonged use in humans has been associated with cutaneous vasculitis and agranulocytosis. We describe the development of a systemic autoimmune disease associated with antineutrophil cytoplasmic antibodies (ANCA) in cocaine users. This complication appears to be linked to combined cocaine and levamisole exposure. Design, setting, participants, & measurements Cases were identified between March 2009 and November 2010 at Massachusetts General Hospital's ANCA laboratory. Cocaine exposure was identified from patient history in all cases. Medical records were reviewed for clinical presentation and for laboratory and diagnostic evaluation. Results Thirty cases of ANCA positivity associated with cocaine ingestion were identified. All had antimyeloperoxidase antibodies and 50% also had antiproteinase 3 antibodies. Complete clinical and laboratory data were available for 18 patients. Arthralgia (83%) and skin lesions (61%) were the most frequent complaints at presentation. Seventy-two percent of patients reported constitutional symptoms, including fever, night sweats, weight loss, or malaise. Four patients had biopsy-proven vasculitis. Two cases of acute kidney injury and three cases of pulmonary hemorrhage occurred. From the entire cohort of 30, two cases were identified during the first 3 months of our study period and nine cases presented during the last 3 months. Conclusions We describe an association between the ingestion of levamisole-contaminated cocaine and ANCA-associated systemic autoimmune disease. Our data suggest that this is a potentially life-threatening complication of cocaine use. Clin J Am Soc Nephrol 6: 2799-2805, 2011. doi: 10.2215/CJN.03440411This publication has 43 references indexed in Scilit:
- Clinicopathologic Features of Agranulocytosis in the Setting of Levamisole-Tainted CocaineAmerican Journal of Clinical Pathology, 2010
- Cocaine adulterant linked to neutropeniaCMAJ : Canadian Medical Association Journal, 2009
- Autoimmune neutropenia in adultsAutoimmunity Reviews, 2009
- Levamisole tainted cocaine causing severe neutropenia in Alberta and British ColumbiaHarm Reduction Journal, 2009
- Levamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cellsClinical and Experimental Immunology, 2007
- Cocaine-Induced PseudovasculitisMayo Clinic Proceedings, 2005
- Levamisole induces interleukin‐18 and shifts type 1/type 2 cytokine balanceImmunology, 2000
- Disseminated autoimmune disease during levamisole treatment of nephrotic syndromePediatric Nephrology, 1999
- Cerebral vasculitis associated with cocaine abuse.Stroke, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990